Connect with us

General News

New CBD Oral Thin Films (OTF) Coming Soon by Canopy Growth and CURE Pharmaceutical

Emma Jay

Published

on

OXNARD, CALIFORNIA – CURE Pharmaceutical will be collaborating with Canopy Growth Corp. to produce low-dose cannabidiol (CBD) oral thin film (OTF) to help administer CBD in the right dosages. This collaboration will leverage CURE’s patented technology, CUREfilm and will also allow the two companies to distribute CBD globally.

“This collaboration builds on our licensing agreement with canopy and accelerates product commercialization,” according to Rob Davidson, the Chief Executive Officer of CURE Pharmaceutical. “We will leverage our recent patented development in cannabis-based drug delivery, to formulate an oral thin film product for optimal efficacy and dosing frequency.”

More About Cure

CURE Pharmaceutical is a registered company under the U.S. Drug Enforcement Agency (DEA). It makes use of its patented CUREfilm technology in developing and manufacturing cannabis-derived and synthetic CBD-based products. It is also a known company that is federally-compliant on the regulations of its industry even during collaborations with other CBD growers and manufacturers.

Emma Jay is one of the most esteemed suppliers of COR cannabis content who loves to find facts and figures as well as stuff plenty of statistics and tidbits backed by research. Stemming with authenticity as a Certified HIPAA Professional in healthcare, Section 504 Coordinator Certificate in Legal and Certified Housing Asset Manager in Real Estate. Boasting over a decade-long stint in community healthcare, EJ will now be helping carry the COR torch into the future.

Join Us On Facebook

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Copyright © 2019 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends: Telegram